|
Home
Search
Study Topics
Glossary
|
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
![]() |
||||||||||||||||||||||||||||||||||||
| Sponsor: | Department of Veterans Affairs |
|---|---|
| Information provided by: | Department of Veterans Affairs |
| ClinicalTrials.gov Identifier: | NCT00018356 |
Purpose
This study's primary objective is to determine the independent and combined effects of progressive resistance muscle strength training and testosterone on the development of sustainable improvements in physical function.
| Condition | Intervention | Phase |
|---|---|---|
|
Muscle Weakness Muscular Atrophy |
Procedure: exercise Drug: testosterone |
Phase IV |
| Study Type: | Interventional |
| Official Title: | Physiologic Effects of PRMS & Testosterone in the Debilitated Elderly |
| Estimated Enrollment: | 88 |
| Study Start Date: | January 1999 |
| Study Completion Date: | August 2006 |
| Primary Completion Date: | July 2006 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
| 1 | Procedure: exercise Drug: testosterone |
Eligibility| Ages Eligible for Study: | 65 Years and older |
| Genders Eligible for Study: | Male |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
The study will be limited to those patients who are metabolically stable and free of metastatic cancer and limiting end organ disease. Their total serum testosterone must be less than 480 and PSA less than 10.
Exclusion Criteria:
Contacts and Locations| United States, Arkansas | |
| Central Arkansas VHS Eugene J. Towbin Healthcare Ctr, Little Rock | |
| No. Little Rock, Arkansas, United States, 72114-1706 | |
| Principal Investigator: | Dennis Sullivan, MD | Central Arkansas VHS Eugene J. Towbin Healthcare Ctr, Little Rock |
More Information
| Responsible Party: | Sullivan, Dennis - Principal Investigator, Department of Veterans Affairs |
| ClinicalTrials.gov Identifier: | NCT00018356 History of Changes |
| Other Study ID Numbers: | AGCG-007-98S |
| Study First Received: | July 3, 2001 |
| Last Updated: | June 22, 2011 |
| Health Authority: | United States: Federal Government |
|
Aging nutrition rehabilitation |
|
Asthenia Muscular Atrophy Muscle Weakness Paresis Atrophy Signs and Symptoms Neuromuscular Manifestations Neurologic Manifestations Nervous System Diseases Pathological Conditions, Anatomical Muscular Diseases Musculoskeletal Diseases Pathologic Processes Testosterone |
Testosterone enanthate Testosterone undecanoate Testosterone 17 beta-cypionate Methyltestosterone Androgens Hormones Hormones, Hormone Substitutes, and Hormone Antagonists Physiological Effects of Drugs Pharmacologic Actions Antineoplastic Agents, Hormonal Antineoplastic Agents Therapeutic Uses Anabolic Agents |